<?xml version="1.0" encoding="UTF-8"?>
<p>Balb/c mice obtained from the animal facility of the Federal University of Viçosa (Central Bioterium), with agreement of Ethics Committee on Animal Use (Comitê de Ética no Uso de Animais—CEUA) of the Federal University of Viçosa, protocol number 63–2013. The 15 day-old, female and male mice were subcutaneously inoculated with high doses of MAYV in the right rear footpad and in the thorax, below the right forelimb. The animals infected in the thorax, below the right forelimb (FLP) received 50 μL (1.25 x 10
 <sup>7</sup> PFU) of viral suspension, while the animals infected in the right rear footpad (FPP) received 10 μL (2.57x10
 <sup>6</sup> PFU) of virus suspension in PBS. Mock-infected mice received the PBS diluent alone. Cohort: 12/group for evaluation of clinical signs and physical test; 8/group for evaluation of pain; 3/group for evaluation of tissue damage and cytokine profile.
</p>
